How Important Is Therapeutic Drug Monitoring in the Prediction and Avoidance of Adverse Reactions? Chris A. GentryKeith A. Rodvold Leading Article 26 October 2012 Pages: 359 - 363
Thalidomide: Rationale for Renewed Use in Immunological Disorders Ulrich SchulerGerhard Ehninger Leading Article 26 October 2012 Pages: 364 - 369
CNS Adverse Events Associated With Antimalarial Agents Penelope A. Phillips-HowardFeiko O. ter Kuile Review Article 26 October 2012 Pages: 370 - 383
A Risk-Benefit Assessment of Cisapride in the Treatment of Gastrointestinal Disorders Jan TackGeorge CoremansJozef Janssens Review Article 26 October 2012 Pages: 384 - 392
Drug Interactions of Clinical Importance D. I. QuinnR. O. Day Special Article 26 October 2012 Pages: 393 - 452